Acquisition of Antiretroviral Medicines 2 AQ2024/900
About This Opportunity
TranslatedThis tender pertains to the acquisition of antiretroviral medicines under the reference AQ2024/900. The objective is to procure essential medications that are crucial for the treatment and management of HIV/AIDS. The tender is aimed at suppliers who can provide high-quality antiretroviral drugs that meet the required specifications and standards. Key requirements include the submission of relevant certifications and compliance with international health regulations. Suppliers must demonstrate their capacity to deliver the medicines within specified timelines and ensure that the products are stored and transported under appropriate conditions to maintain their efficacy. The procurement process is part of a broader initiative to enhance healthcare services and improve the quality of life for individuals living with HIV/AIDS. Interested parties are encouraged to review the detailed specifications and submit their bids in accordance with the guidelines provided. The location of the procurement is not specified, but it is likely to be within the jurisdiction of the contracting authority responsible for healthcare services. This tender represents an important opportunity for pharmaceutical companies to contribute to public health efforts by supplying vital medications.
This is a supplies contract in the health and medical services, information and communication technology and transport and logistics sectors, with a focus on Pharmaceuticals, Infectious Diseases and Logistics. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 3.3 million.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThe tender identified as "Aquisição de Medicamentos Anti retrovíricos 2 AQ2024/900" is part of the public procurement process in Portugal, specifically focusing on the acquisition of antiretroviral medications.
This procurement initiative aims to ensure the availability of essential pharmaceutical products necessary for the treatment and management of HIV/AIDS within the Portuguese healthcare system.
The contracting authority for this tender is not explicitly stated; however, it is managed through the Portal BASE, which serves as a centralized platform for public contracts across mainland Portugal and its autonomous regions. This initiative underscores the government's commitment to providing critical healthcare resources and improving patient outcomes in the fight against HIV/AIDS.
Typical requirements for this type of tender generally include the provision of high-quality antiretroviral medications that meet regulatory standards, detailed documentation demonstrating compliance with safety and efficacy guidelines, and the ability to meet specified delivery timelines. Bidders may also be required to show evidence of previous experience in supplying similar pharmaceutical products, along with appropriate certifications and licenses.
Additionally, potential suppliers should be prepared to engage in discussions regarding pricing structures, delivery logistics, and ongoing support services, ensuring that the medications supplied are both accessible and affordable. This tender represents a significant opportunity for pharmaceutical companies to contribute to public health in Portugal while adhering to rigorous procurement standards and enhancing their presence in the healthcare market.
Data provenance
This notice is sourced from base_gov_pt and was originally published on February 16, 2026. Last refreshed 7 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saúde de Gaia/Espinho, E. P. E.
Unidade Local de Saúde de Gaia/Espinho, E. P. E. has issued 488 procurement notices on BidsFactory, including 0 currently open and 479 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Industry & Manufacturing. All notices are published for Portugal. Notices are distributed via base_gov_pt and TED - Tenders Electronic Daily (EU). Most recent publication: June 18, 2026.
Frequently asked questions about this tender
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to VIIVHIV HEALTHCARE, UNIPESSOAL LDA. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Unidade Local de Saúde de Gaia/Espinho, E. P. E. in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €3,306,107. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.